SCHEMBL28569815

SCHEMBL28569815

CN1CCN(c2ccc(C(=O)OC(C)(C)C)cc2)C([N+](=O)[O-])C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.38
MAPT P10636 2/20 0.38
LMNA P02545 1/20 0.38
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA9 Q16790 1/20 0.37
CA14 Q9ULX7 1/20 0.37
GPR119 Q8TDV5 2/20 0.34
SIRT6 Q8N6T7 2/20 0.34
SIRT2 Q8IXJ6 1/20 0.34
SIRT1 Q96EB6 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.33
POLB P06746 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33
SCN1A P35498 1/20 0.32
SCN2A Q99250 1/20 0.32
SCN3A Q9NY46 1/20 0.32
HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21753191 0.84 MAPT (0.40) ALDH1A1MAPTLMNACA12CA1
SCHEMBL28569818 0.81 CA12 (0.40) ALDH1A1CA12CA1CA2CA9
SCHEMBL21753071 0.81 MAPT (0.37) ALDH1A1MAPTLMNACA12CA1
SCHEMBL28947519 0.70 KCNJ1 (0.46) ALDH1A1MAPTHPGD
SCHEMBL27807066 0.70 ALDH1A1 (0.40) ALDH1A1MAPTLMNASIRT6POLB
SCHEMBL27807000 0.69 ALDH1A1 (0.44) ALDH1A1LMNAGPR119L3MBTL1SIGMAR1
SCHEMBL27648888 0.68 KMT2A (0.43) ALDH1A1MAPTLMNAPOLBSCN1A
SCHEMBL28576696 0.67 GPR119 (0.38) ALDH1A1MAPTLMNACA12CA1
SCHEMBL22692234 0.67 GPR119 (0.42) ALDH1A1CA12CA1CA2CA9
SCHEMBL8159908 0.67 MAPT (0.51) ALDH1A1MAPTLMNACA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112939897-A Preparation method and application of broad-spectrum anti-cancer drug enrotinib intermediate 上海珈睿医药科技有限公司 2021-06-11 CN claimed
CN-112939897-A Preparation method and application of broad-spectrum anti-cancer drug enrotinib intermediate 上海珈睿医药科技有限公司 2021-06-11 CN disclosed
CN-112939897-A Preparation method and application of broad-spectrum anti-cancer drug enrotinib intermediate 上海珈睿医药科技有限公司 2021-06-11 CN disclosed